Chaudhary Hamad, Stewart C Matthew, Webster Kimberly, Herbert Robert J, Frick Kevin D, Eisele David W, Gourin Christine G
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, U.S.A.
Department of Health Policy and Management, the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A.
Laryngoscope. 2017 Mar;127(3):631-641. doi: 10.1002/lary.26311. Epub 2016 Sep 23.
To examine 30-day readmission rates and associations with risk factors, survival, length of hospitalization, and costs in elderly patients with laryngeal and oropharyngeal squamous cell cancer (SCC).
Retrospective cross-sectional analysis of Surveillance, Epidemiology, and End Results-Medicare data.
We evaluated 1,518 patients diagnosed with laryngeal or oropharyngeal SCC from 2004 to 2007 who underwent primary surgery using cross-tabulations, multivariate regression modeling, and survival analysis.
Thirty-day readmission occurred in 14.1% of hospitalizations. Readmission was more likely in patients with postoperative complications during initial hospitalization (24.8% vs. 4.5%, P < 0.001), and was associated with an increased 30-day mortality incidence rate (5.1% vs. 0.9%; P < 0.001). On multivariate analysis, 30-day readmission was significantly associated with advanced stage (odds ratio [OR] = 1.81 [1.13-2.90]), comorbidity (OR = 2.69 [1.65-4.39]), divorced/separated marital status (OR = 2.00 [1.19-3.38]), preoperative tracheostomy (OR = 3.39 [1.55-7.44]), major surgical procedures (OR = 2.58 [1.68-3.97]), greater length of initial hospitalization (OR = 1.72 [1.09-2.71]), pneumonia (OR = 2.86 [1.28-6.40]), postoperative dysphagia (OR = 5.97 [2.48-15.83]), and cardiovascular events (OR = 5.84 [1.89-17.96]). Thirty-day readmission was significantly associated with 30-day mortality (OR = 5.89 [2.21-15.70) and higher 1-year mortality (68.0% vs. 89.2%, P < 0.001). The mean incremental costs of surgical care were significantly greater for patients with unplanned readmission ($15,123 [$10,514-$19,732]), after controlling for all other variables.
Unplanned readmissions are associated with increased short- and long-term mortality and costs. Elderly patients with advanced disease, advanced comorbidity, lack of spousal support, pretreatment organ dysfunction, more extensive surgery, postoperative pneumonia, postoperative dysphagia, and prolonged hospitalization are at increased risk of 30-day readmission. These findings suggest a need for targeted interventions before, during, and after hospitalization to reduce morbidity, mortality, and excess costs in this high-risk population.
2c. Laryngoscope, 127:631-641, 2017.
研究喉及口咽鳞状细胞癌(SCC)老年患者的30天再入院率及其与风险因素、生存率、住院时长和费用的相关性。
对监测、流行病学及最终结果-医疗保险数据进行回顾性横断面分析。
我们评估了2004年至2007年间诊断为喉或口咽SCC且接受初次手术的1518例患者,采用交叉表、多变量回归模型和生存分析。
14.1%的住院患者发生了30天再入院。初次住院期间有术后并发症的患者再入院可能性更高(24.8%对4.5%,P<0.001),且与30天死亡率发生率增加相关(5.1%对0.9%;P<0.001)。多变量分析显示,30天再入院与晚期疾病(比值比[OR]=1.81[1.13 - 2.90])、合并症(OR = 2.69[1.65 - 4.39])、离婚/分居婚姻状况(OR = 2.00[1.19 - 3.38])、术前气管切开术(OR = 3.39[1.55 - 7.44])、大型外科手术(OR = 2.58[1.68 - 3.97])、初次住院时间更长(OR = 1.72[1.09 - 2.71])、肺炎(OR = 2.86[1.28 - 6.40])、术后吞咽困难(OR = 5.97[2.48 - 15.83])和心血管事件(OR = 5.84[1.89 - 17.96])显著相关。30天再入院与30天死亡率(OR = 5.89[2.21 - 15.70])和1年更高死亡率(68.0%对89.2%,P<0.001)显著相关。在控制所有其他变量后,计划外再入院患者的手术护理平均增量成本显著更高(15,123美元[10,514 - 19,732美元])。
计划外再入院与短期和长期死亡率及费用增加相关。患有晚期疾病、严重合并症、缺乏配偶支持、预处理器官功能障碍、手术范围更广、术后肺炎、术后吞咽困难和住院时间延长的老年患者30天再入院风险增加。这些发现表明需要在住院前、住院期间和住院后进行有针对性的干预,以降低这一高危人群的发病率、死亡率和额外费用。
2c。《喉镜》,2017年,第127卷,第631 - 641页